Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5

Massimiliano Secchi, Lia Vassena, Sébastien Morin, Dominique Schols, Luca Vangelista

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5'. Together they form a unique fingerprint.

Medicine & Life Sciences